Abstract: A battery backup system for use with vehicle telematics electronics includes a phone module configured for operation by the vehicle telematics electronics. The system further includes a battery module configured to provide power to the phone module and a circuit configured to determine that backup power is needed. The circuit causes the battery module to provide the backup power to the phone module for completing a transmission via the phone module. The battery module can provide the backup power to the phone module without providing operating power to the vehicle telematics electronics.

Abstract: A battery backup system for use with vehicle telematics electronics includes a phone module configured for operation by the vehicle telematics electronics. The system further includes a battery module configured to provide power to the phone module and a circuit configured to determine that backup power is needed. The circuit causes the battery module to provide the backup power to the phone module for completing a transmission via the phone module. The battery module can provide the backup power to the phone module without providing operating power to the vehicle telematics electronics.

Abstract: The invention is directed to chimeric polypeptides, e.g., bispecific antibodies, comprising a chemokine receptor binding domain and a T cell surface polypeptide or cell toxin binding domain, nucleic acids that encode them, and methods of making and using them. The chimeric polypeptides of the invention can include, be bound to, or attached to, a cell toxin. The invention is also directed to pharmaceutical compositions and methods for making and using them, including the treatment of immunological disorders, such as autoimmune diseases, and for the targeted elimination of cells, e.g., T lymphocytes and other cells latently infected with a primate immunodeficiency virus, such as a human immunodeficiency virus, e.g., HIV-1.

Abstract: A two-component protective equine leg wrap (10) is provided which is designed for application to the lower part (16) of a horse's leg. The wrap (10) includes a panel (12) having a fetlock joint-receiving section (28) which is adapted to be applied to the leg part (16) and secured by means of connection straps (50). A separate reinforcing strap (14) also forms a part of the wrap (10) and is configured for attachment to the applied panel (10) to provide additional fetlock joint support and protection. The panel (12) preferably includes an inner laminate layer (30) made up of a foam body having a plurality of phase change microcapsules embedded therein to lessen heat buildup, and an outer breathable laminate layer (32).

Abstract: The invention is directed to chimeric polypeptides, e.g., bispecific antibodies, comprising a chemokine receptor binding domain and a T cell surface polypeptide or cell toxin binding domain, nucleic acids that encode them, and methods of making and using them. The chimeric polypeptides of the invention can include, be bound to, or attached to, a cell toxin. The invention is also directed to pharmaceutical compositions and methods for making and using them, including the treatment of immunological disorders, such as autoimmune diseases, and for the targeted elimination of cells, e.g., T lymphocytes and other cells latently infected with a primate immunodeficiency virus, such as a human immunodeficiency virus, e.g., HIV-1.

Abstract: A two-component protective equine leg wrap (10) is provided which is designed for application to the lower part (16) of a horse's leg. The wrap (10) includes a panel (12) having a fetlock joint-receiving section (28) which is adapted to be applied to the leg part (16) and secured by means of connection straps (50). A separate reinforcing strap (14) also forms a part of the wrap (10) and is configured for attachment to the applied panel (10) to provide additional fetlock joint support and protection. The panel (12) preferably includes an inner laminate layer (30) made up of a foam body having a plurality of phase change microcapsules embedded therein to lessen heat buildup, and an outer breathable laminate layer (32).

Abstract: The invention is directed to chimeric polypeptides, e.g., bispecific antibodies, comprising a chemokine receptor binding domain and a T cell surface polypeptide or cell toxin binding domain, nucleic acids that encode them, and methods of making and using them. The chimeric polypeptides of the invention can include, be bound to, or attached to, a cell toxin. The invention is also directed to pharmaceutical compositions and methods for making and using them, including the treatment of immunological disorders, such as autoimmune diseases, and for the targeted elimination of cells, e.g., T lymphocytes and other cells latently infected with a primate immunodeficiency virus, such as a human immunodeficiency virus, e.g., HIV-1.

Abstract: Improved orthopaedic supports (10) and prosthesis suspension devices (36) are provided in the form of tubular bodies (12, 42) formed of resilient, stretchable material and configured to fit about a human limb. The inner surfaces (32) of the tubular bodies (12, 42) have anti-slip material (24, 26, 50) applied thereto. The anti-slip material (24, 26, 50) is preferably a synthetic resin material having a coefficient of static friction greater than that of the inner surfaces (32).

Abstract: An improved knee-supporting sleeve (10) is provided having posterior and proximal anterior panels (12, 20) formed of thin relatively highly stretchable material, with a distal anterior panel (22) formed of less stretchable composite materials. The sleeve (10) thus provides maximum-support and joint conformity, together with good breathability and thermal properties. The sleeve (10) also has a patella-receiving opening (42) and an adjacent buttress (52) housed within a selectively openable compartment (44) to trim and/or shift buttress (52) therein, so that a desirable "lateral J" buttress may be provided for either a left or right knee.

Abstract: An improved orthopaedic support (10) is provided in the form of an elongated, open-ended tubular body (12) having a continuous sidewall (13), with the latter presenting a recessed region (18) intermediate the ends (14, 16) for anatomically conforming with a limb joint such as a knee. The sidewall (13) is entirely free of transverse dart-defining seams at the recessed region (18). In preferred forms, the body (12) is fabricated with only a single seam (26) extending the length thereof. The body (12) is formed from fabric-faced closed cell neoprene rubber synthetic resin material, and the seam (26) is adhesively formed and covered with heat-applied seam tape (28, 30).